Literature DB >> 19196964

Anti-laminin gamma-1 pemphigoid.

Teruki Dainichi1, Sadamu Kurono, Bungo Ohyama, Norito Ishii, Noriko Sanzen, Maria Hayashi, Chisei Shimono, Yukimasa Taniguchi, Hiroshi Koga, Tadashi Karashima, Shinichiro Yasumoto, Detlef Zillikens, Kiyotoshi Sekiguchi, Takashi Hashimoto.   

Abstract

Anti-p200 pemphigoid has been characterized by autoantibodies to an unidentified 200-kDa protein (p200) of the dermal-epidermal junction. The objective of this study was to identify p200. We performed 2D gel electrophoresis of dermal extracts and immunoblotting with patients' sera, followed by MS analysis of a unique protein band. The protein band corresponded to laminin gamma1. Anti-laminin gamma1 mAb reacted with the anti-p200 immunoprecipitates by immunoblotting. Sera from 32 patients with anti-p200 pemphigoid showed 90% reactivity to the recombinant products of laminin gamma1. None of the healthy control sera reacted with laminin gamma1. By immunoblotting, reactivity of a patient's serum with p200 was competitively inhibited by adding anti-laminin gamma1 C-terminus mAb. Purified anti-p200 IgG also inhibited the reactivity of this mAb to dermal laminin gamma1. Most laminin gamma1-positive sera showed reactivity with recombinant laminin gamma1 C-terminal E8 fragment. Reactivity of patients' sera and purified IgG to dermal laminin gamma1 was higher than reactivity to blood vessel laminin gamma1 under reducing conditions. These results suggest that laminin gamma1 is the autoantigen for patients with anti-p200 pemphigoid. The autoantibodies may specifically recognize dermal laminin gamma1 with unique posttranslational modifications. The epitope is localized to the 246 C-terminal amino acids within the coiled-coil domain. The 9 C-terminal residues are known to be critically involved in laminin recognition by integrins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196964      PMCID: PMC2650346          DOI: 10.1073/pnas.0809230106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen.

Authors:  Y Kawahara; D Zillikens; K B Yancey; M P Marinkovich; Z Nie; T Hashimoto; T Nishikawa
Journal:  J Dermatol Sci       Date:  2000-06       Impact factor: 4.563

2.  Probing the integrin-binding site within the globular domain of laminin-511 with the function-blocking monoclonal antibody 4C7.

Authors:  Hiroyuki Ido; Kenji Harada; Yoshiko Yagi; Kiyotoshi Sekiguchi
Journal:  Matrix Biol       Date:  2005-12-01       Impact factor: 11.583

3.  Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins.

Authors:  Ryoko Nishiuchi; Junichi Takagi; Maria Hayashi; Hiroyuki Ido; Yoshiko Yagi; Noriko Sanzen; Tsutomu Tsuji; Masashi Yamada; Kiyotoshi Sekiguchi
Journal:  Matrix Biol       Date:  2006-01-18       Impact factor: 11.583

4.  Quantitative proteome analysis using D-labeled N-ethylmaleimide and 13C-labeled iodoacetanilide by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Sadamu Kurono; Tamie Kurono; Naoka Komori; Satomi Niwayama; Hiroyuki Matsumoto
Journal:  Bioorg Med Chem       Date:  2006-10-16       Impact factor: 3.641

Review 5.  Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.

Authors:  Amrei Dilling; Christian Rose; Takashi Hashimoto; Detlef Zillikens; Iakov Shimanovich
Journal:  J Dermatol       Date:  2007-01       Impact factor: 4.005

6.  The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2.

Authors:  Silke C Hofmann; Ursula Voith; Takako Sasaki; Ralph M Trüeb; Roswitha Nischt; Leena Bruckner-Tuderman
Journal:  J Invest Dermatol       Date:  2007-07-19       Impact factor: 8.551

7.  The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid.

Authors:  R Y Chan; K Bhol; N Tesavibul; E Letko; R K Simmons; C S Foster; A R Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

8.  The requirement of the glutamic acid residue at the third position from the carboxyl termini of the laminin gamma chains in integrin binding by laminins.

Authors:  Hiroyuki Ido; Aya Nakamura; Reiko Kobayashi; Shunsuke Ito; Shaoliang Li; Sugiko Futaki; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

9.  Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen.

Authors:  D Zillikens; A Ishiko; M F Jonkman; I Chimanovitch; H Shimizu; T Hashimoto; E B Bröcker
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

10.  The targeted deletion of the LAMC1 gene.

Authors:  N Smyth; H S Vatansever; M Meyer; C Frie; M Paulsson; D Edgar
Journal:  Ann N Y Acad Sci       Date:  1998-10-23       Impact factor: 5.691

View more
  23 in total

Review 1.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 2.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Authors:  Ralf J Ludwig; Luca Borradori; Luis A Diaz; Takashi Hashimoto; Michael Hertl; Saleh M Ibrahim; Marcel F Jonkman; Yasuo Kitajima; Dédée F Murrell; Enno Schmidt; Hiroshi Shimizu; John R Stanley; David T Woodley; Detlef Zillikens
Journal:  J Invest Dermatol       Date:  2014-09       Impact factor: 8.551

Review 4.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 5.  Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.

Authors:  Michael Olbrich; Axel Künstner; Mareike Witte; Hauke Busch; Anke Fähnrich
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].

Authors:  Katharina Antonia Drerup; Ulrike Wehkamp
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

7.  [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].

Authors:  K M Kaune; M Kasperkiewicz; D Tams; M Bergmann; M Zutt
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

Review 8.  Regulation of the Immune System by Laminins.

Authors:  Thomas Simon; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2017-07-03       Impact factor: 16.687

Review 9.  Autoimmunity versus autoinflammation--friend or foe?

Authors:  Nobuo Kanazawa; Georgi Tchernev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-07-09

10.  Autoantibodies Against Multiple Epitopes in Bp180 and Laminin Gamma-1 in Subepidermal Blistering Skin Disease Associated with Psoriatic Erythroderma.

Authors:  Haruna Goto-Hamano; Keiko Ito; Kumiko Sakamoto-Kimura; Tadashi Terui; Bungo Ohyama; Takashi Hashimoto; Hiroyuki Hara
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.